SUMER JACQUELYN L

CIK 00018448242 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001844824

Recent Transactions

21 trades

Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-12-18$9.67/sh−3,480→ 135,432 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-02-25$8.53/sh−3,756→ 136,895 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2025-02-19+100,000→ 100,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-02-19+50,000→ 140,651 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-12-18$11.41/sh−3,482→ 90,651 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-02-22+100,000→ 100,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-02-22+50,000→ 94,133 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-12-21$8.50/sh−1,400→ 44,133 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-12-18$8.22/sh−290→ 45,533 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-06-20$12.94/sh−291→ 45,823 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-05-18$8.76/sh−291→ 46,114 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-04-18$10.71/sh−290→ 46,405 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-03-20$11.32/sh−305→ 46,695 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2023-02-17+93,500→ 93,500 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-02-17+47,000→ 47,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2022-08-15+190,000→ 190,000 total
Sale
GENOCEA BIOSCIENCES, INC.
Common Stock
2022-06-01$0.06/sh−2,500→ 43,000 total
Award
GENOCEA BIOSCIENCES, INC.
Common Stock
2022-03-15+37,500→ 45,500 total
Award
GENOCEA BIOSCIENCES, INC.
Stock Option (Right to Buy)
2022-03-15+112,500→ 112,500 total
Award
GENOCEA BIOSCIENCES, INC.
Restricted Stock Unit
2021-03-15+100,000→ 100,000 total
Award
GENOCEA BIOSCIENCES, INC.
Stock Option (Right to Buy)
2021-03-01$3.07/sh+115,000→ 115,000 total

Companies

Recent Filings

Address

C/O CULLINAN THERAPEUTICS, INC. ONE MAIN STREET, SUITE 1350

CAMBRIDGE, MA, 02142

View on SEC.gov